Skip to main navigation Skip to search Skip to main content

Hepatocarcinogenesis in viral Hepatitis B infection: the role of HBx and p53.

Research output: Contribution to journalReview articlepeer-review

42 Citations (Scopus)

Abstract

Infection of Hepatitis B Virus (HBV) is a risk factor of chronic active hepatitis (CAH), hepatic cirrhosis and hepatocellular carcinoma (HCC). Infection of HBV may develop to HCC without antecedent hepatic cirrhosis. Pathogenesis of HBV causing malignant changes has not been fully understood. HBx, a protein of HBV, is an activator of transcription process involved in hepatocarcinogenesis. Most of human cancer associated with mutation of p53, a Tumor Suppressor Genes, a protein serves as cellular protection for growth and cell division, which is one of predisposition factor of hepatocarcinoma. Some studies indicate the correlation between mutation / inactivation of p53 and HBV protein x (HBx) in hepatocarcinogenesis. In that process, HBx will suppress p53 function, which will lead to ineffective liver cell division and resulting in HCC.

Original languageEnglish
Pages (from-to)154-159
Number of pages6
JournalACTA MEDICA INDONESIANA
Volume38
Issue number3
Publication statusPublished - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Hepatocarcinogenesis in viral Hepatitis B infection: the role of HBx and p53.'. Together they form a unique fingerprint.

Cite this